Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
A Non-Interventional, Post-Marketing Surveillance (NI-PMS) study whose objectives were to
assess the impact of pregabalin on subjects' pain, quality of sleep, and their general
wellbeing, as well as the tolerance and safety of pregabalin in subjects with neuropathic
pain.
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.